Page results
-
A team at UCLH and UCL have developed new methods to predict outcomes for pregnancies where there are issues with poor growth of the baby inside the womb.
-
During this time of visiting restrictions, we have introduced "Letters To Loved Ones" at UCLH.
-
The comprehensive review, co-authored by UCLH Director of Research Prof Bryan Williams, recommends approaches including mindfulness practices and reducing exposure to air polluion.
-
The designs of a new breathing aid developed by engineers at UCL and Formula One working with clinicians at UCLH have been made freely available to support the global response to Covid-19.
-
A UCLH and UCL study has identified how a subset of immune cells are activated to kill cancerous cells, a finding in mice which could hold the key to new powerful therapies against cancer.
-
Patient information for patients dealing with difficult feelings. This information will give you useful advice about what to do if you find yourself in a crisis.
-
Brain surgery survivor’s labour of love to bring Chelsea garden to hospital
-
The research team said the placenta acted as a barrier to transmission.
-
Fears that people with high blood pressure are more at risk from severe Covid-19 because it is easier for the virus to enter their cells and tissues have been laid to rest, thanks to research involving UCLH.
-
We have been incredibly saddened to have had seven members of staff lose their lives to COVID-19.
File results
-
FOI/2021/0559 - Department of Respiratory Physiology recall letter
-
FOI/2021/0572 - Dermatological and rheumatological conditions
-
FOI/2021/0577 - Patient brought to A&E paralysed
-
FOI/2021/0591 - Laboratory/ Pathology information system
-
FOI/2021/0593 - Contact centre/ Call centre contract
-
FOI/2021/0601 - Treatment Guidelines with Systemic lupus erythematosus (SLE) / Lupus nephritis (LN)
-
FOI/2021/0616 - Overseas visitors and migrants
-
FOI/2021/0618 - Number of patient admissions to A&E
-
FOI/2021/0626 - Cardiac output monitors and manufacturer associated disposable products
-
FOI/2021/0100 - DNACPR orders issued - March 2019 to January 2021